The Headache Inducing Effects of Cilostazol on Migraine Patients

Danish Headache Center

Status: Completed

Conditions: Migraine

Treatments: Drug: Placebo; Drug: Cilostazol

Study type: Interventional

Funder types: Other

Identifiers

NCT01841827

H-2-2013-033

Details and patient eligibility

About

We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.

Enrollment: 14 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with migraine without aura according to the IHS criteria from 2004.
• Healthy besides migraine

Exclusion criteria

• Tension-type headache more than 3 days per month
• Other types of primary headaches
• Pregnancy
• History of vascular diseases or psychiatric diseases.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

14 participants in 2 patient groups, including a placebo group

Cilostazol

Active Comparator group

Description:

Capsule of Cilostazol 200 mg are taken orally on each study day

Treatment:

Drug: Cilostazol

Placebo

Placebo Comparator group

Description:

A capsule of placebo containing starch are taken orally on each study day.

Treatment:

Drug: Placebo